Our mission is to generate new therapies for cardiovascular-metabolic disorders, and reverse unfavorable aspects of aging.
- What's new -
July, 2021
Frontiers in Cardiovascular Medicine; IF 6.05! Awesome!!
https://www.frontiersin.org/journals/cardiovascular-medicine/sections/cardiovascular-metabolism#
April, 2021
Ippei Shimizu appointed as a leader of U45-ISHR Japanese section.
(International Society of Heart Research).
April, 2021
We moved to Juntendo University, Tokyo, Japan.
March, 2021
Congrats!
Winner; Yung Ting Hsiao; YIA competition for International Students, 84th Annual Scientific Meeting of Japanese Circulation Society
2021 (JCS2021)
March 2021
Published
Hsiao YT*, Shimizu I*,**, Wakasugi T, Jiao S, Watanabe T,
Yoshida Y, Ikegami R, Hayashi Y, Suda M, Katsuumi G, Nakao M, Ozawa T, Kashimura T, Ozaki K, Hanawa H, Minamino T**. Cardiac Mitofusin-1 is Reduced in Non-responding Patients
with Idiopathic Dilated Cardiomyopathy. Sci Rep. , Mar24; 11(1):6722, 2021. *Co-first author, **Co-corresponding author
